Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VBI Vaccines Inc.    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about VBI VACCINES INC.
09/24VBI VACCINES : to Present at Upcoming Scientific Conferences
BU
09/21VBI VACCINES : signs agreement with Canada to develop COVID-19 vaccine by 2022
RE
09/17VBI VACCINES : Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurr..
BU
09/14VBI VACCINES : to Present Additional Biomarker Data from VBI-1901 Phase 1/2a Stu..
BU
08/31VBI VACCINES : Sci-B-Vac® Phase 3 Data at EASL 2020
PU
08/31VBI VACCINES : Presents Phase 3 Sci-B-Vac® Data at EASL 2020
BU
08/26VBI VACCINES : selects two COVID-19 vaccine candidates for human trials
RE
08/26VBI VACCINES :  VBI Vaccines Announces Preclinical Coronavirus Program Data and ..
BU
08/20VBI VACCINES : Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral..
BU
08/05VBI VACCINES : Awarded Up to CAD$56 Million Contribution from Canadian Governmen..
BU
07/31VBI VACCINES : Announces Second Quarter 2020 Financial Results and Provides Corp..
BU
07/20VBI VACCINES : Thinking about buying stock in Tonix Pharmaceuticals, Heat Biolog..
PR
06/22VBI-1901 : AACR Data, Partial Response and Biomarker Strategy
PU
06/22VBI-1901 : AACR Data and Clinical Update
PU
06/22VBI VACCINES ANNOUNCES DATA FROM VBI : Partial Response Observed, Promising Biom..
BU
More most relevant news
All news about VBI VACCINES INC.
09/24VBI VACCINES : to Present at Upcoming Scientific Conferences
BU
09/21VBI VACCINES : signs agreement with Canada to develop COVID-19 vaccine by 2022
RE
09/17VBI VACCINES : Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurr..
BU
09/14VBI VACCINES : to Present Additional Biomarker Data from VBI-1901 Phase 1/2a Stu..
BU
08/31VBI VACCINES : Sci-B-Vac® Phase 3 Data at EASL 2020
PU
08/31VBI VACCINES : Presents Phase 3 Sci-B-Vac® Data at EASL 2020
BU
08/26VBI VACCINES : selects two COVID-19 vaccine candidates for human trials
RE
08/26VBI VACCINES :  VBI Vaccines Announces Preclinical Coronavirus Program Data and ..
BU
08/20VBI VACCINES : Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral..
BU
08/05Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccines
RE
More news
News in other languages on VBI VACCINES INC.
2019VBI VACCINES : annonce la phase 2a de l'évaluation clinique du candidat-vaccin V..
2019VBI VACCINES : veröffentlicht klinische Evaluierung der Phase 2a des Krebsimpfst..
Press releases
09/24VBI VACCINES : to Present at Upcoming Scientific Conferences
BU
09/17VBI VACCINES : Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurr..
BU
09/14VBI VACCINES : to Present Additional Biomarker Data from VBI-1901 Phase 1/2a Stu..
BU
08/31VBI VACCINES : Sci-B-Vac® Phase 3 Data at EASL 2020
PU
08/31VBI VACCINES : Presents Phase 3 Sci-B-Vac® Data at EASL 2020
BU
More press releases
Upcoming event on VBI VACCINES INC.